Influence of milled glass fiber fillers on mode I & mode II interlaminar fracture toughness of epoxy resin for fabrication of glass/epoxy composites

The present work is focused on improving mode I and mode II delamination resistance of glass/epoxy composite laminates (50 wt. % of glass fibers) with milled glass fibers, added in various amounts (2.5, 5, 7.5 and 10% of the epoxy weight). Including fillers in the interlayer enhances the delamination resistance by providing a bridging effect, therefore demanding additional energy to initiate the crack in the interlaminar domain, which results in turn in enhanced fracture toughness. The maximal increase of mode I and mode II fracture toughness and of flexural strength was obtained by the addition of 5% milled glass fiber. The mechanism observed suggests that crack propagation is stabilized even leading to its arrest/deflection, as a considerable amount of milled glass fiber filler was oriented transverse to the crack path. In contrast, at higher filler loading, tendency towards stress concentration grows due to local agglomeration and improper dispersion of excess fillers in inter/intralaminar resin channel, causing poor adhesion to the matrix, which leads to reduction in fracture toughness, strength and strain to failure. Fractured surfaces analyzed using scanning electron microscopy (SEM) revealed a number of mechanisms, such as crack deflection, individual debonding and filler/matrix interlocking, all contributing in various ways to improve fracture toughness

DEVELOPMENT AND VALIDATION OF STABILITY-INDICATING RP-UPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF TEZACAFTOR AND IVACAFTOR IN FORMULATIONS

Objective: Aim of the present research work was to develop a sensitive, rapid and accurate, stability-indicating RP-UPLC method for the simultaneous estimation of tezacaftor and ivacaftor in formulations. Methods: The chromatographic separation of the mixture of tezacaftor and ivacaftor was attained in isocratic method utilizing a mobile phase of 0.1 % orthophosphoric acid and acetonitrile in the proportion of 50:50%v/v utilizing a HSS C18 column which has dimensions of 100×2.1 mm, 1.7 m particle size and the flow rate of 0.3 ml/min. The detection system was monitored at 292 nm wavelength maximum with 1.5 ml injection volume. The present method was validated as per the guidelines given by the ICH for specificity, accuracy, sensitivity, linearity and precision. Results: The retaining time for tezacaftor and ivacaftor were achieved at 1.071 min and 0.530 min, respectively. Tezacaftor, ivacaftor and their combined drug formulation were exposed to thermal, acidic, oxidative, photolytic, and alkaline conditions. The developed method was highly sensitive, rapid, precise and accurate than the earlier reported methods. The total run time was decreased to 2.0 min; hence, the technique was more precise and economical. Stability studies directed for the suitability of the technique for degradation studies of tezacaftor and ivacaftor. Conclusion: The projected method can be utilized for routine analysis in the quality control department in pharmaceutical trades

XPS and Raman Studies on (002) Oriented Nanocrystalline ZnO Films Showing Temperature Dependent Optical Red Shift

Abstract Nanocrystalline zinc oxide (ZnO) thin films have been prepared on glass substrates at different temperatures through planar RF-magnetron sputtering. Structural properties with respect to substrate temperature have been studied with xray diffraction (XRD) patterns. The stoichiometry in the films is studied with X-ray photoemission spectroscopy (XPS). The shifts in the absorption edge of the films in the optical spectrum with the variation of substrate temperature are examined. Raman spectrum showed an increase in the average scattering intensity of the phonon peak at 580 cm -1 with respect to the reduction of particle size. The variation of conductivity of prepared ZnO films with respect to substrate temperature is studied well

A technical perspective on integrating artificial intelligence to solid-state welding

The implementation of artificial intelligence (AI) techniques in industrial applications, especially solid-state welding (SSW), has transformed modeling, optimization, forecasting, and controlling sophisticated systems. SSW is a better method for joining due to the least melting of material thus maintaining Nugget region integrity. This study investigates thoroughly how AI-based predictions have impacted SSW by looking at methods like Artificial Neural Networks (ANN), Fuzzy Logic (FL), Machine Learning (ML), Meta-Heuristic Algorithms, and Hybrid Methods (HM) as applied to Friction Stir Welding (FSW), Ultrasonic Welding (UW), and Diffusion Bonding (DB). Studies on Diffusion Bonding reveal that ANN and Generic Algorithms can predict outcomes with an accuracy range of 85 – 99%, while Response Surface Methodology such as Optimization Strategy can achieve up to 95 percent confidence levels in improving bonding strength and optimizing process parameters. Using ANNs for FSW gives an average percentage error of about 95%, but using metaheuristics refined it at an incrementally improved accuracy rate of about 2%. In UW, ANN, Hybrid ANN, and ML models predict output parameters with accuracy levels ranging from 85 to 96%. Integrating AI techniques with optimization algorithms, for instance, GA and Particle Swarm Optimization (PSO) significantly improves accuracy, enhancing parameter prediction and optimizing UW processes. ANN’s high accuracy of nearly 95% compared to other techniques like FL and ML in predicting welding parameters. HM exhibits superior precision, showcasing their potential to enhance weld quality, minimize trial welds, and reduce costs and time. Various emerging hybrid methods offer better prediction accuracy

Emotion Processing Deficit in Euthymic Bipolar Disorder: A Potential Endophenotype

Background: Emotion processing deficits have been described in patients with bipolar disorder (BD) and are considered one of the core cognitive abnormalities in BD with endophenotype potential. However, the literature on specific impairments in emotion processing cognitive strategies (directive/cortical/higher versus intuitive/limbic/lower) in euthymic adult BD patients and healthy first-degree relatives/high-risk (HR) subjects in comparison with healthy controls (HCs) is sparse. Methods: We examined facial emotion recognition deficits (FERD) in BD (N = 30), HR (N = 21), and HC (N = 30) matched for age (years), years of education, and sex using computer-administered face emotions–Matching And Labeling Task (eMALT). Results: The three groups were significantly different based on labeling accuracy scores for fear and anger (FA) (P \u3c 0.001) and sad and disgust (SD) (P \u3c 0.001). On post-hoc analysis, HR subjects exhibited a significant deficit in the labeling accuracy of FA facial emotions (P \u3c 0.001) compared to HC. The BD group was found to have significant differences in all FA (P = 0.004) and SD (P = 0.003) emotion matching as well as FA (P = 0.001) and SD (P \u3c 0.001) emotion labeling accuracy scores. Conclusions: BD in remission exhibits FERD in general, whereas specific labeling deficits of fear and anger emotions, indicating impaired directive higher order aspect of emotion processing, were demonstrated in HR subjects. This appears to be a potential endophenotype. These deficits could underlie the pathogenesis in BD, with possible frontolimbic circuitry impairment. They may have potential implications in functional recovery and prognosis of BD

Changes in the intestinal microbiota following the administration of azithromycin in a randomised placebo-controlled trial among infants in south India.

Macrolides are among the most widely prescribed antibiotics worldwide. However, their impact on the gut's bacterial microbiota remains uncertain. We characterised the intestinal microbiota in 6-11 month-old infants in India who received a 3-day course of azithromycin or placebo during a randomised trial of oral poliovirus vaccine immunogenicity (CTRI/2014/05/004588). In 60 infants per study arm, we sequenced the V4 region of the bacterial 16S rRNA gene in stool samples collected before and 12 days after finishing treatment. We also tested for the presence of common bacterial, viral, and eukaryotic enteropathogens in the same samples using real-time PCR in a Taqman array card (TAC) format. Azithromycin induced a modest decline in microbiota richness and a shift in taxonomic composition driven by a reduction in the relative abundance of Proteobacteria and Verrucomicrobia (specifically Akkermansia muciniphila). The former phylum includes pathogenic strains of Escherichia coli and Campylobacter spp. that declined in prevalence based on the TAC assay. These findings differ from previous observations among older children and adults in Europe and North America, suggesting that the effects of azithromycin on the bacterial microbiota may be specific to the age and geographic setting of its recipients

Sacrificial-template-free synthesis of core-shell C@Bi2S3 heterostructures for efficient supercapacitor and H-2 production applications

Core-shell heterostructures have attracted considerable attention owing to their unique properties and broad range of applications in lithium ion batteries, supercapacitors, and catalysis. Conversely, the effective synthesis of Bi2S3 nanorod core@ amorphous carbon shell heterostructure remains an important challenge. In this study, C@Bi2S3 core-shell heterostructures with enhanced supercapacitor performance were synthesized via sacrificial-template-free one-pot-synthesis method. The highest specific capacities of the C@Bi2S3 core shell was 333.43 F g(-1) at a current density of 1 A g(-1). Core-shell-structured C@Bi2S3 exhibits 1.86 times higher photocatalytic H-2 production than the pristine Bi2S3 under simulated solar light irradiation. This core-shell feature of C@Bi2S3 provides efficient charge separation and transfer owing to the formed heterojunction and a short radial transfer path, thus efficiently diminishing the charge recombination; it also facilitates plenty of active sites for the hydrogen evolution reaction owing to its mesoporous nature. These outcomes will open opportunities for developing low-cost and noble-metal-free efficient electrode materials for water splitting and supercapacitor applications

The RESPITE trial: remifentanil intravenously administered patient-controlled analgesia (PCA) versus pethidine intramuscular injection for pain relief in labour: study protocol for a randomised controlled trial

Background The commonest opioid used for pain relief in labour is pethidine (meperidine); however, its effectiveness has long been challenged and the drug has known side effects including maternal sedation, nausea and potential transfer across the placenta to the foetus. Over a third of women receiving pethidine require an epidural due to inadequate pain relief. Epidural analgesia increases the risk of an instrumental vaginal delivery and its associated effects. Therefore, there is a clear need for a safe, effective, alternative analgesic to pethidine. Evidence suggests that remifentanil patient-controlled analgesia (PCA) reduces epidural conversion rates compared to pethidine; however, no trial has yet investigated this as a primary endpoint. We are, therefore, comparing pethidine intramuscular injection to remifentanil PCA in a randomised controlled trial. Methods/design Women in established labour, requesting systemic opioid pain relief, will be randomised to either intravenously administered remifentanil PCA (intervention) or pethidine intramuscular injection (control) in an unblinded, 1:1 individual randomised trial. Following informed consent, 400 women in established labour, who request systemic opioid pain relief, from NHS Trusts across England will undergo a minimised randomisation by a computer or automated telephone system to either pethidine or remifentanil. In order to balance the groups this minimisation is based on four parameters; parity (nulliparous versus multiparous), maternal age (<20, 20 < 30, 30 < 40, 40+ years), ethnicity (South Asian (Pakistani/Indian/Bangladeshi) versus Other) and induced versus spontaneous labour. The effectiveness of pain relief provided by each technique will be recorded every 30 min after time zero, until epidural placement, delivery or transfer to theatre, quantified by Visual Analogue Scale. Incidence of maternal side effects including sedation, delivery mode, foetal distress requiring delivery, neonatal status at delivery and rate of initiation of breastfeeding within the first hour of birth will also be recorded. Maternal satisfaction with her childbirth experience will be determined by a postpartum questionnaire prior to discharge from the delivery ward. Discussion The RESPITE trial’s primary outcome is the proportion of women who have an epidural placed for pain relief in labour in each arm. Trial Registration Current Controlled Trials registration number: ISRCTN29654603. Registered on 23 July 2013